alexa Vitamin E-TPGS Stabilized Lapatinib Nanocrystals: In-vivo Pharmacokinetic And Pharmacodynamic Evaluation
ISSN 2472-1042

Pharmacoeconomics: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
February 27-28, 2017 Amsterdam, Netherlands

Agrawal Satish, Hafsa Ahmad, Roshan Sikandar, Abhishek Arya and Anil Kumar Dwivedi
Central Drug Research Institute- CSIR, India
Posters & Accepted Abstracts: Pharmacoeconomics
DOI: 10.4172/2472-1042.C1.003
Aim: The aim of this study is the development of vitamin E-TPGS stabilized Lapatinib Nanocrystals (LPT-NCs) to improve its anticancer activity. Methods: Nanocrystals were prepared through high pressure homogenization and the optimized formulation was further characterized on the basis of in-vitro and in-vivo evaluations. Results: Optimized formulation had 282.2±9.48 nm average particle size, 0.288±0.006 PDI and 33.63±3.59 mv zeta potential values. Microscopic examination displayed formation of rod shaped nano-sized crystals. DSC thermogram showed that crystallinity of Lapatinib was retained in formulation. Formulation significantly enhanced the saturation solubility of LPT in water. LPT-NCs were found to be stable during 4 months study period when stored at 4ºC. In-vivo pharmacokinetics study comprising of crude lapatinib suspension and LPT-NCs by oral route performed on healthy adult female Sprauge-Dawley rats demonstrated significant enhancement in AUC, Cmax and reduction in clearance of LPT in LPT-NCs treated group. Tumor regression study performed in 4T1 cells induced syngeneic breast cancer female BALB/c mice revealed significant reduction in tumor burden and overall improvement in survival in LPT-NCs treated group compared to crude Lapatinib suspension. Conclusion: LPT-NCs significantly enhanced anticancer activity of LPT by improving its oral bioavailability possibly due to solubility enhancement and P-gp inhibition.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version